Ryan Nguyen, DO, discusses enrollment disparities in pivotal clinical trials in oncology.
Ryan Nguyen, DO
Advertisement
Articles by Ryan Nguyen, DO
Oncology practices across the United States have rapidly increased telehealth use in 2020 to mitigate the risk of coronavirus disease 2019 (COVID-19) to patients with cancer who are at particular risk of complications.
Advertisement
Latest Updated Articles
Dr. Nguyen on Enrollment Disparities in Pivotal Clinical Trials in OncologyPublished: June 23rd 2021 | Updated:
Telehealth Is Here to Stay: Opportunities and Challenges for Cancer CarePublished: October 20th 2020 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
FDA Approves Daratumumab and Hyaluronidase Plus VRd for Newly Diagnosed Multiple Myeloma
2
PD-L1 Expression Is More Predictive of Response to Pembrolizumab on Metastatic Sites in High-Grade Serous Ovarian Cancer
3
Dr Braunstein on the FDA Approval of Subcutaneous Daratumumab With VRd For Newly Diagnosed Multiple Myeloma
4
Ixazomib-Containing Combinations Signal Potential for More PI-Based Regimens in R/R Multiple Myeloma
5